)
Visual
test
Mauna Kea Technologies
Mauna Kea Technologies (ALMKT) investor relations material
Mauna Kea Technologies Q4 2025 TU earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q4 2025 TU earnings summary15 Jan, 2026
Executive summary
Q4 2025 revenue increased 19% year-over-year on a reported basis and 29% at constant exchange rates, driven by strong U.S. performance.
U.S. sales grew 65% (82% at CER), now representing 77% of total Q4 revenue, up from 60% in Q4 2024.
CellTolerance achieved €1 million in global sales for FY 2025, confirming it as a second growth pillar.
Commercial activity outside the U.S. rebounded post-Safeguard proceedings, with new market entries in Australia and Austria.
Financial highlights
Q4 2025 total revenue was €2.41 million, up from €1.74 million in Q4 2024.
FY 2025 revenue reached €7.99 million, a 5% increase year-over-year (9% at CER).
U.S. system sales rose 284% (324% at CER) in Q4, with four new systems sold at 96% of list price.
U.S. probe sales increased 83% (101% at CER), while PPU revenue declined 23% (-16% at CER).
EMEA & ROW Q4 revenue declined 39% due to the end of a non-recurring J&J payment, but core system and probe sales grew 23% and 68%, respectively.
Outlook and guidance
Entering 2026 with improved visibility and confidence, supported by U.S. market underpenetration, a new partnership, and international expansion.
The Tae Woong Medical USA partnership is expected to be operational by end of Q1 2026, with no fixed costs for Mauna Kea.
What is the margin impact of the US PPU decline?
What are the key drivers for CellTolerance growth?
How will Tae Woong partnership impact US sales?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Latest summaries
- TimeTickerHeadlineOpen
- 6 FebHTOO
Resale registration for 71,429 shares via warrant, with proceeds only on exercise; financial risks persist. - 6 FebVSAT
Q3 revenue up 3% to $1.16B, net income $25M, strong cash flow, Ligado boost, satellite focus. - 6 FebWEC
Targets 7–8% EPS growth, $37.5B capex, and coal exit by 2032 amid surging data center demand. - 6 FebBR
Q2 FY26 recurring revenue grew 8% and adjusted EPS guidance was raised to 9-12%. - 6 FebFFWM
Merger vote includes new non-voting stock class with limited conversion and no voting rights. - 6 FebKKR
Charter amendments seek to modernize governance and establish one share, one vote by 2026. - 6 FebARI
Proposed $9B real estate loan portfolio acquisition highlights disciplined, long-term strategy. - 6 FebSMCI
Q2 revenue jumped 123% to $12.7B, with FY26 guidance raised to at least $40B. - 6 FebRJF
Record revenues and assets, higher dividend, and acquisitions despite lower net income. - 6 FebFFIE
Raising capital for global EV and AI expansion, with regulatory and dilution risks highlighted.
Next Mauna Kea Technologies earnings date
Q1 2026 TU16 Apr, 2026
Mauna Kea Technologies
Next Mauna Kea Technologies earnings date
Q1 2026 TU16 Apr, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Mauna Kea Technologies SA is a French medical device company that specializes in developing and marketing advanced optical biopsy systems. The company's flagship product, Cellvizio, is a probe-based Confocal Laser Endomicroscopy (pCLE) platform. This technology allows physicians to obtain real-time, high-resolution cellular images during endoscopic procedures, primarily for detecting abnormalities in the gastrointestinal and pulmonary tracts, particularly in cancer patients. The Cellvizio system is designed to improve diagnostic accuracy and support more immediate treatment decisions, with applications across multiple medical specialties. Mauna Kea Technologies is headquartered in Paris, France, and its shares are listed on the Euronext Paris.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage